Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine
Abstract
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine
Yan J, Xie W, Wang Q, Li Y, Feng X, et al. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2011;11(5):. doi:
The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine
Min L, Haodong C. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2008;8(1):. doi:
The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine
Kim S. The optimal threshold: Baseline serum hepatitis B virus DNA and alanine transaminase levels can predict the 2-Year on-treatment virological response to lamivudine. Hepat Mon. 2010;10(3):. doi:
Effect and Predictive Elements for 52 Weeks’ Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B
Zhu X, Lu L, Wang Y, Xu K, Li D, et al. Effect and Predictive Elements for 52 Weeks’ Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B. Hepat Mon. 2011;11(12):e93029. doi: https://doi.org/10.5812/kowsar.1735143X.795
Lamivudine Resistance in Iranian Chronic Hepatitis B Patients
Fallahian F, Alavian S, Kayvani H, Alaeddini F, Zamani F. Lamivudine Resistance in Iranian Chronic Hepatitis B Patients. Shiraz E-Med J. 2009;11(2):20359. doi:
Crossmark
Checking
- Scopus by DOI: 4
Last Update: 2 weeks ago
- Scopus by Title: 5
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 2
Last Update: 1 day ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC